01 5SHORLA
01 511771701
01 5Blank
01 5Y
01 52034-10-29
Patent Expiration Date : 2034-10-29
US Patent Number : 11771701
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 212479
Patent Use Code : U-3703
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-10-29
Patent Expiration Date : 2034-10-29
US Patent Number : 11771701
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 212479
Patent Use Code : U-3702
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-10-29
Patent Expiration Date : 2034-10-29
US Patent Number : 11771701
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 212479
Patent Use Code : U-3701
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-10-29
Patent Expiration Date : 2034-10-29
US Patent Number : 11771701
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 212479
Patent Use Code : U-3700
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-10-29
Patent Expiration Date : 2034-10-29
US Patent Number : 11771701
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 212479
Patent Use Code : U-3704
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-10-29
